Publications:44
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Daniel Dickstein, MD
Radiation Oncology
About Me
Daniel R. Dickstein, MD, is an Assistant Professor of Radiation Oncology at the Icahn School of Medicine at Mount Sinai in New York City. He specializes in prostate cancer and sexual health, with particular expertise in the treatment of gay and bisexual men with prostate cancer.
His commitment to improving prostate cancer care for gay and bisexual men began when a patient asked how treatment might impact receptive anal intercourse. In prostate cancer care, conversations about sexual health almost always focus on erections and heterosexual intercourse—where a wealth of information already exists. For this patient’s question, however, there were no answers.
Determined to change that, Dr. Dickstein set out to build the evidence himself. He received an American Society of Clinical Oncology (ASCO) Young Investigator Award and has since published multiple high-impact papers, including the first studies demonstrating that prostate cancer treatments affect sexual health differently in gay and bisexual men depending on their preferred sexual behavior.
He has presented this work in invited lectures in Washington, DC, Seattle, and Vienna. He serves on the American Radium Society’s Genitourinary Appropriate Use Criteria Committee and on the advisory board for Nature Reviews Urology. What began as an effort to answer one patient’s question has grown into an evidence-based clinical practice where patients—gay, bisexual, and heterosexual alike—can discuss their sexual health concerns openly, safely, and without judgment.
Key Publications
Prostate Cancer and Sexual Health in Gay and Bisexual Men
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer. Nature Reviews Urology, 2023.
Sexual health outcomes in sexual minority and heterosexual men after prostate radiation therapy. International Journal of Radiation Oncology • Biology • Physics, 2025.
Treatment choice and sexual health outcomes in gay and bisexual men with prostate cancer. Prostate Cancer and Prostatic Diseases, 2025.
Anal Cancer and Receptive Anal Intercourse
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus. Nature Reviews Gastroenterology & Hepatology, 2024.
Editorials
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself. Nature Reviews Urology, 2024.
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer. Nature Reviews Urology, 2022.
Media
Let's talk about sex: tailoring prostate-cancer care for LGBT+ people. Nature Outlook, 2022.
Language
English
Position
ASSISTANT PROFESSOR | Radiation Oncology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Clinical Focus
- Anal Cancer
- Bladder Cancer
- Prostate Cancer
- Radiation Therapy
- Testicular Cancer
Education
BA, Bowdoin College
MD, Icahn School of Medicine at Mount Sinai
Internship, Internal Medicine
Greenwich Hospital-Yale University Internal Medicine GME
Residency, Radiation Oncology
Icahn School of Medicine At Mount Sinai
Awards
2024
Alpha Omega Alpha Medical Honor Society
2024
Roentgen Resident Research Award
Radiologic Society of North America
2023
Young Investigator Award
American Society of Clinical Oncology
2023
Sigma Xi Scientific Honor Society
Research
My research focuses on improving sexual health outcomes after cancer treatment, with particular emphasis on receptive anal intercourse and gay and bisexual men with prostate and anal cancers. I study how treatments such as surgery, radiation, and systemic therapies affect the anatomy and physiology of sexual function and pleasure. By generating evidence on how different treatments impact sexual function across sexual behaviors, my goal is to help oncologists tailor treatment recommendations and design interventions that preserve pleasure while minimizing dysfunction.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- HealthFirst Medicare
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy. Luca F. Valle, Tommy Jiang, Ashton Rosenbloom, Nicholas G. Zaorsky, Clara Hwang, Abhishek Solanki, Daniel Dickstein, Timur Mitin, Thomas Schroeder, Louis Potters, Shane Lloyd, Tim Showalter, Hilary P. Bagshaw, R. Jeffrey Karnes, Karen E. Hoffman, Paul L. Nguyen, Amar U. Kishan. European urology oncology
- Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate Radiation Therapy. Daniel R. Dickstein, Thodori Kapouranis, Keith Sigel, Christopher W. Wheldon, Eva Nvepu, Noelle Marie Javier, Robert Stewart, Matthew Galsky, John Sfakianos, Joshua D. Safer, Richard Stock, Karyn Goodman, B. R.Simon Rosser, Kathryn E. Flynn, Deborah C. Marshall. International Journal of Radiation Oncology Biology Physics
- Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes. Alexander Rühle, Maria Weymann, Max Behrens, Johannes Olbrich, Carmen Kut, Sebastian N. Marschner, Marlen Haderlein, Alexander Fabian, Carolin Senger, Benjamin P. Bakst, Johannes Kraft, Jens von der Grün, Esmée Lauren Looman, Eric Chen, Justus Domschikowski, Alev Altay-Langguth, Goda Kalinauskaite, Victor Lewitzki, Marcelo Bonomi, Dukagjin Blakaj, Sachin R. Jhawar, Sujith Baliga, Ahmed N. Elguindy, Konstantinos Ferentinos, Constantinos Zamboglou, Jörg Andreas Müller, Chris Leucht, Daniel R. Dickstein, Sören Schnellhardt, Erik Haehl, Peter Hambsch, Thomas Kuhnt, Clemens Seidel, Claus Belka, Arnulf Mayer, Heinz Schmidberger, Anca Ligia Grosu, Panagiotis Balermpas, Carmen Stromberger, Harald Binder, Harry Quon, Nils H. Nicolay. Radiotherapy and Oncology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Dickstein has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.